Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
short-term use only
Endocr Rev 2020;41:bnaa004.PubMedPMC 5
GLP-1-RA such as liraglutide [4], semaglutide [5], and the dual agonist tirzepatide [6], activating both the GLP1- and the gastric-inhibitory polypeptide receptor (GIP-R), have been shown to significantly reduce body weight, making them a promising therapeutic option for the treatment of obesity
do not pre-mix solutions
For better results, consult your doctor
Public discourse surrounding GLP-1RAs thus remains dynamic and unsettled
US$ 25.92
US$ 20.71
US$ 25.97
US$ 20.52
US$ 28.34
